Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of remimazolam besylate vs propofol for induction and maintenance of general anesthesia in elective surgery
CTR20200595Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Jun 2020; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on CTR20200595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200595.